Privileged Structures Revisited
Privileged structures inspire compound library design in medicinal chemistry. We performed a comprehensive analysis of 1.4 million bioactive compounds, with the aim of assessing the prevalence of certain molecular frameworks. We used the Shannon entropy formalism to quantify the promiscuity of the most frequently observed atom scaffolds across the annotated target families. This analysis revealed an apparent inverse relationship between hydrogen‐bond‐acceptor count of a scaffold and its potential promiscuity. The results further suggest that chemically easily accessible scaffolds can serve as templates for the generation of bespoke compound libraries with differing degrees of multiple target engagement, and heterocyclic, sp3‐rich frameworks are particularly suited for target‐focused library design. The outcome of our study enables us to place some of the many narratives surrounding the concept of privileged structures into a critical context.
Top-30
Journals
|
1
2
3
4
5
6
|
|
|
Organic Letters
6 publications, 5.71%
|
|
|
Molecules
4 publications, 3.81%
|
|
|
Journal of Heterocyclic Chemistry
4 publications, 3.81%
|
|
|
Journal of Organic Chemistry
4 publications, 3.81%
|
|
|
Scientific Reports
3 publications, 2.86%
|
|
|
ACS Omega
3 publications, 2.86%
|
|
|
Journal of Medicinal Chemistry
3 publications, 2.86%
|
|
|
F1000Research
2 publications, 1.9%
|
|
|
International Journal of Molecular Sciences
2 publications, 1.9%
|
|
|
Monatshefte fur Chemie
2 publications, 1.9%
|
|
|
Molecular Diversity
2 publications, 1.9%
|
|
|
Nature Reviews Chemistry
2 publications, 1.9%
|
|
|
Mendeleev Communications
2 publications, 1.9%
|
|
|
European Journal of Organic Chemistry
2 publications, 1.9%
|
|
|
ChemMedChem
2 publications, 1.9%
|
|
|
ChemistrySelect
2 publications, 1.9%
|
|
|
ACS Chemical Biology
2 publications, 1.9%
|
|
|
ACS Catalysis
2 publications, 1.9%
|
|
|
Journal of the American Chemical Society
2 publications, 1.9%
|
|
|
Green Chemistry
2 publications, 1.9%
|
|
|
Expert Opinion on Drug Discovery
2 publications, 1.9%
|
|
|
Biomedicines
1 publication, 0.95%
|
|
|
Current Topics in Medicinal Chemistry
1 publication, 0.95%
|
|
|
MolBank
1 publication, 0.95%
|
|
|
Electrochem
1 publication, 0.95%
|
|
|
Chemistry
1 publication, 0.95%
|
|
|
Diagnostics
1 publication, 0.95%
|
|
|
Nature Reviews Drug Discovery
1 publication, 0.95%
|
|
|
Biochemical Pharmacology
1 publication, 0.95%
|
|
|
1
2
3
4
5
6
|
Publishers
|
5
10
15
20
25
|
|
|
American Chemical Society (ACS)
24 publications, 22.86%
|
|
|
Wiley
15 publications, 14.29%
|
|
|
Elsevier
14 publications, 13.33%
|
|
|
Springer Nature
13 publications, 12.38%
|
|
|
MDPI
12 publications, 11.43%
|
|
|
Royal Society of Chemistry (RSC)
9 publications, 8.57%
|
|
|
Bentham Science Publishers Ltd.
3 publications, 2.86%
|
|
|
Taylor & Francis
3 publications, 2.86%
|
|
|
F1000 Research
2 publications, 1.9%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
2 publications, 1.9%
|
|
|
Walter de Gruyter
1 publication, 0.95%
|
|
|
Frontiers Media S.A.
1 publication, 0.95%
|
|
|
Belgorod National Research University
1 publication, 0.95%
|
|
|
AIP Publishing
1 publication, 0.95%
|
|
|
Spandidos Publications
1 publication, 0.95%
|
|
|
American Scientific Publishers
1 publication, 0.95%
|
|
|
The Society of Synthetic Organic Chemistry, Japan
1 publication, 0.95%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.95%
|
|
|
5
10
15
20
25
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.